Free Trial

Vaccinex (VCNX) SEC Filings & 10K Form

Vaccinex logo
$1.21 +0.20 (+19.80%)
(As of 12/20/2024 05:32 PM ET)

Recent Vaccinex SEC Filings

DateFilerForm TypeView
12/17/2024
8:32 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:15 PM
Vaccinex (Subject)
Zauderer Maurice (Filed by)
Form SC 13D/A
10/25/2024
3:11 PM
Vaccinex (Filer)
Form 424B3
10/24/2024
11:15 PM
Vaccinex (Filer)
Form EFFECT
10/16/2024
3:44 PM
Vaccinex (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/09/2024
3:37 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:11 PM
Vaccinex (Filer)
Form D
Notice of Exempt Offering of Securities 
09/20/2024
4:15 PM
FCMI Parent Co. (Filed by)
Vaccinex (Subject)
Form SC 13D/A
09/20/2024
3:57 PM
Vaccinex (Subject)
Zauderer Maurice (Filed by)
Form SC 13D/A
09/19/2024
7:30 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
5:04 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
4:17 PM
Vaccinex (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
7:35 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
8:05 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
3:16 PM
Vaccinex (Filer)
Form 424B3
07/07/2024
11:15 PM
Vaccinex (Filer)
Form EFFECT
06/27/2024
3:41 PM
Vaccinex (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/06/2024
7:36 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
4:24 PM
Vaccinex (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2024
11:15 PM
Vaccinex (Filer)
Form EFFECT
05/09/2024
4:08 PM
Vaccinex (Filer)
Form 424B3
05/08/2024
11:29 AM
Vaccinex (Filer)
Form S-3/A
04/26/2024
4:16 PM
Vaccinex (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/25/2024
2:00 PM
Vaccinex (Filer)
Form 10-K/A
04/22/2024
3:33 PM
FCMI Parent Co. (Reporting)
FRIEDBERG ALBERT (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
11:15 PM
Vaccinex (Filer)
Form EFFECT
04/16/2024
3:55 PM
Vaccinex (Filer)
Form 424B3
04/12/2024
3:25 PM
Vaccinex (Filer)
Form D
Notice of Exempt Offering of Securities 
04/12/2024
3:15 PM
Vaccinex (Filer)
Form D
Notice of Exempt Offering of Securities 
04/02/2024
3:23 PM
Vaccinex (Filer)
Form DEF 14A
04/02/2024
3:11 PM
Vaccinex (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/01/2024
7:53 PM
FCMI Parent Co. (Reporting)
FRIEDBERG ALBERT (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
7:54 PM
Vaccinex , L.L.C. (0001747866) (Reporting)
Vaccinex (Issuer)
Zauderer Maurice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:54 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
12:27 PM
Vaccinex (Filer)
Form 424B5
03/27/2024
7:39 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
3:31 PM
Vaccinex (Issuer)
Zauderer Maurice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
3:31 PM
Sanchez Jill (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
3:32 PM
Smith Ernest S. (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
3:33 PM
Evans Elizabeth E. (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
3:31 PM
Sanchez Jill (Reporting)
Vaccinex (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
This Crypto Is Set to Explode in December (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

03/04/2024
3:19 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
9:10 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
7:06 AM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
3:32 PM
FCMI Parent Co. (Reporting)
FRIEDBERG ALBERT (Reporting)
Vaccinex (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
3:34 PM
Vaccinex , L.L.C. (0001747866) (Reporting)
Vaccinex (Issuer)
Zauderer Maurice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
7:20 AM
Vaccinex (Filer)
Form 8-K/A
02/07/2024
5:55 PM
HIRSCHMAN ORIN (Filed by)
Vaccinex (Subject)
Form SC 13G/A
02/07/2024
2:43 PM
Vaccinex (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2024
11:15 PM
Vaccinex (Filer)
Form EFFECT
01/19/2024
3:40 PM
Vaccinex (Filer)
Form 424B3
01/10/2024
4:16 PM
Vaccinex (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/08/2024
3:16 PM
Vaccinex (Filer)
Form DEF 14A
12/28/2023
3:31 PM
Vaccinex (Issuer)
Van Strydonck, Gerald E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:15 PM
Vaccinex (Filer)
Form PRE 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VCNX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners